Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1999
11/23/1999US5989884 Polypeptides of the histidyl transfer rna synthetase family; for screening of antibiotics, bactericides, and bacteristats for treatment and prevention of clamydial infections; diagnosis
11/23/1999US5989866 FGF homologs
11/23/1999US5989863 Human ankyrin family protein
11/23/1999US5989856 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
11/23/1999US5989837 Immortalized human keratinocyte cell line
11/23/1999US5989834 Contacting nonneuronal cells transfected with vector; gene expression
11/23/1999US5989828 Binding to matrix; vaccines
11/23/1999US5989822 Diagnosis and treatment of cancer, neurodegenerative and autoimmune diseases; gene expression
11/23/1999US5989807 Polymerase chain reactions
11/23/1999US5989805 Immortal avian cell line to grow avian and animal viruses to produce vaccines
11/23/1999US5989550 Materials and methods for immunocontraception
11/23/1999US5989538 Mpl ligand analogs
11/23/1999US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
11/18/1999WO1999058977A1 Method of direct selection of antigen-specific t cells
11/18/1999WO1999058693A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999WO1999058692A2 Human apoptosis associated proteins
11/18/1999WO1999058691A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
11/18/1999WO1999058690A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
11/18/1999WO1999058688A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
11/18/1999WO1999058686A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport
11/18/1999WO1999058684A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
11/18/1999WO1999058681A2 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999WO1999058675A2 Human genes and gene expression products v
11/18/1999WO1999058667A1 Rhotekin, a putative target for rho
11/18/1999WO1999058660A1 97 human secreted proteins
11/18/1999WO1999058659A2 Methods and compositions for expression of transgenes in plants
11/18/1999WO1999058654A2 Transgenic plants with a modified activity of a plastidial adp/atp translocator
11/18/1999WO1999058646A1 Genetically-modified fibroblasts and the use thereof
11/18/1999WO1999058645A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058641A2 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999WO1999058573A1 Diagnosis and treatment of hepatic disorders
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058563A2 Moraxella catharralis proteins
11/18/1999WO1999058559A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity
11/18/1999WO1999058558A2 Cell signaling proteins
11/18/1999WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999WO1999058155A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999WO1999058143A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
11/18/1999WO1999058042A2 Specially devised neuronal implants for reconstruction of damaged central nervous system
11/18/1999WO1999050406A3 Growth differentiation factor-9 regulatory sequences and uses therefor
11/18/1999WO1999050393A3 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage
11/18/1999WO1999048915A9 Orphan nuclear receptor
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999047649A9 Polymerase chimeras
11/18/1999WO1999047643A9 Selection subtraction approach to gene identification
11/18/1999WO1999047642A9 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
11/18/1999WO1999047557A3 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
11/18/1999WO1999047552A3 Genes encoding mlo proteins and conferring fungal resistance upon plants
11/18/1999WO1999047163A3 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
11/18/1999WO1999046370A3 Expression of trehalose biosynthetic genes in plants
11/18/1999WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999045962A9 Transgenic non-human animals capable of producing heterologous antibodies
11/18/1999WO1999045949A3 Use of follistatin to modulate gdf-8 and bmp-11
11/18/1999WO1999043830A3 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
11/18/1999WO1999038985A3 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/18/1999WO1999038981A3 Human protein kinase molecules
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999036550A3 Human protease molecules
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
11/18/1999DE19822050A1 Chemical or biological reactions on surface of particles, retained in container permeable to reaction fluid, especially for growing cells
11/18/1999DE19803651A1 Immobilization of spermatozoa for intracytoplasmic sperm injection
11/18/1999CA2332109A1 97 human secreted proteins
11/18/1999CA2331311A1 Nucleic acid molecules encoding wheat enzymes involved in startch synthesis
11/18/1999CA2331115A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999CA2331061A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999CA2330000A1 Diagnosis and treatment of hepatic disorders
11/18/1999CA2328521A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999CA2328518A1 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
11/18/1999CA2328508A1 Nucleic acid molecules encoding wheat enzymes involved in starch synthesis
11/18/1999CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999CA2328130A1 Moraxella catarrhalis proteins
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999CA2327546A1 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999CA2327354A1 Human apoptosis associated proteins
11/18/1999CA2327351A1 Cell signaling proteins
11/18/1999CA2326722A1 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957167A1 Production of heterodimeric human fertility hormones
11/17/1999EP0957165A2 Optimizing cells for endogenous gene activation
11/17/1999EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line
11/17/1999EP0957161A1 Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of the same
11/17/1999EP0957160A1 Method for inducing immunosuppressive cells and culturing device to be used therefor
11/17/1999EP0956357A1 Invertase inhibitor
11/17/1999EP0956355A2 Method for immortalizing cells
11/17/1999EP0956354A1 Recombinant n-proteinase, and the production, methods and uses thereof
11/17/1999EP0956353A1 MANIPULATION OF CELLULOSE AND/OR $g(b)-1,4-GLUCAN
11/17/1999EP0956351A1 A tumor necrosis factor related ligand
11/17/1999EP0956350A1 Human chloride channel protein (hccp)
11/17/1999EP0956347A1 M. tuberculosis rna polymerase alpha subunit
11/17/1999EP0956342A1 Methods for identifying vasoprotective agents
11/17/1999EP0956341A2 Mouse cardiac muscle cell line, hl-1
11/17/1999EP0956340A1 In culture proliferation of human pancreatic endocrine cells